Mistletoe is the English common name for over 1200 species of a semi-parasitic plant that grows on trees worldwide, though only viscum album (European or common mistletoe) is used in the treatment of cancer and inflammatory conditions. References to mistletoe as a sacred plant and remedy appear throughout history and date as far back as the writings of Hippocrates (c. 460 - c. 370) and Pliny the Elder (AD 23-79), but it was only through the indications of Rudolf Steiner, in the early 1920's, that it became known that mistletoe could be used for the treatment of cancer. It was then developed as an injection.
    Since that time, European oncologists have been using the liquid extract of the mistletoe plant to improve survival in patients with cancer and to improve quality of life by reducing the side-effects of chemotherapy and radiation, such as nausea, vomiting and lack of appetite, as well as diminishing tumor-related pain. Mistletoe injections are currently among the most widely used complementary cancer treatments in Europe. It is approved for palliative care use in several European countries, but not yet in the United States. Until further clinical testing is done in the US, oncologists cannot offer this treatment as standard of care for cancer patients. Mistletoe is being administered in the US by complementary medicine practitioners, but mistletoe is not approved by the FDA for cancer treatment. 

    The clinical effectiveness of mistletoe extracts in cancer has been investigated in a great number of studies and clinical trials, primarily in Europe. A clinical trial is currently being conducted in the US at Johns Hopkins School of Medicine. 

    Patients seeking a physician trained in mistletoe therapy should visit the Patient Resources page.

    More information for both licensed practitioners and patients can be found within the following links:

    Links to the four main producers of European mistletoe:


    Helixor (only currently available in German)

    WALA (producer of Iscusin)


    There are numerous additional resources available to currently-licensed prescribers (MDs, DOs, NDs, NPs and PAs):

    • A free information packet that includes select clinical guidelines (by request, sent by mail within 7-10 business days)
    • Recordings of select presentations from the 2019 Mistletoe Therapy Best Practices Course for Prescribers that took place in Baltimore in June, 2019 (by request, 7 hours of material presented by expert faculty, available for purchase at $395; does include some slides within presentations. Discounts applied for PAAM members and those who attended the live course.)
    • Complete collection of all slide presentations from the 2019 Mistletoe Therapy Best Practices Course for Prescribers (by request, available for purchase at $125. Reduced pricing for those who attended the live course.)
    • PAAM Training Webinar Series: Mistletoe Use in Cancer Therapy (Part 1 and Part 2), presented in 2017.
      Available for direct purchase through Vimeo: Part 1 and Part 2
    All requests for the free information packet and the Best Practices Course recordings and slides are vetted before being further processed. Please provide the requested information below and press "Subscribe". We will respond to your request with 5-7 business days. Failure to provide information in any of the boxes below may result in a prolonged delay in your request.

    Selections below reflect full pricing. Discounts are applied at time of invoicing. Once your license number is verified you will receive a follow-up email and/or invoice for the requested materials. Upon payment of the online invoice, links, passwords and materials will be provided. 

    Questions? Email us at paam@anthroposophy.org

    Request for Mistletoe Resources

    * indicates required
    / / ( mm / dd / yyyy )
    I am interested in:

    Physicians' Association for Anthroposophic Medicine (PAAM)
    PO Box 4039
    Grand Junction, CO 81502
    Powered by Wild Apricot Membership Software